InsiderTrades.com logo

NTLA Insider Trading

Insider Ownership Percentage: 3.10%
Insider Buying (Last 12 Months): $1,003,000.00
Insider Selling (Last 12 Months): $677,745.91

Intellia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Intellia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intellia Therapeutics Share Price & Price History

Current Price: $12.38
Price Change: ▼ Price Decrease of -0.865 (-6.53%)
As of 03/27/2026 02:55 PM ET

This chart shows the closing price history over time for NTLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Intellia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026Birgit C SchultesEVPSell8,508$9.21$78,358.6898,533View SEC Filing Icon  
1/5/2026James BastaEVPSell10,397$9.21$95,756.37101,528View SEC Filing Icon  
1/5/2026John M LeonardCEOSell34,146$9.21$314,484.661,013,339View SEC Filing Icon  
10/1/2025Birgit C SchultesEVPSell31$17.38$538.78105,184View SEC Filing Icon  
10/1/2025Michael P DubeCAOSell1,871$17.38$32,517.9855,266View SEC Filing Icon  
8/20/2025William J. ChaseDirectorBuy100,000$10.03$1,003,000.00134,693View SEC Filing Icon  
7/23/2025J Dulac IIIEVPSell7,462$14.02$104,617.24106,062View SEC Filing Icon  
7/2/2025Michael P DubeCAOSell2,503$9.95$24,904.8557,137View SEC Filing Icon  
7/1/2025Eliana ClarkEVPSell1,022$9.82$10,036.0495,369View SEC Filing Icon  
7/1/2025Jesse GoodmanDirectorSell1,547$9.23$14,278.8124,359View SEC Filing Icon  
4/29/2025Muna BhanjiDirectorSell265$8.50$2,252.5019,203View SEC Filing Icon  
1/29/2025Muna BhanjiDirectorSell265$9.97$2,642.0519,468View SEC Filing Icon  
1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26941,115View SEC Filing Icon  
1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.9645,640View SEC Filing Icon  
1/2/2025Eliana ClarkEVPSell556$12.03$6,688.6871,470View SEC Filing Icon  
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.1247,012View SEC Filing Icon  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.6571,470View SEC Filing Icon  
3/4/2024James BastaEVPSell2,297$32.99$75,778.0381,571View SEC Filing Icon  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.2543,927View SEC Filing Icon  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.7854,372View SEC Filing Icon  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.9040,585View SEC Filing Icon  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58846,486View SEC Filing Icon  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.5011,996View SEC Filing Icon  
7/31/2023Muna BhanjiDirectorSell265$42.33$11,217.4512,261View SEC Filing Icon  
7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.1012,526View SEC Filing Icon  
7/3/2023Eliana ClarkEVPSell360$40.51$14,583.6045,146View SEC Filing Icon  
6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.0045,146View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NTLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Intellia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC50,946$0.46M0.0%-6.6%0.043%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.140,218$1.26M0.0%+1.7%0.119%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC27,260$0.25M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.433,290$3.90M0.0%+5.8%0.374%Search for SEC Filing on Google Icon
2/19/2026Axxcess Wealth Management LLC21,399$0.19M0.0%+20.1%0.018%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV10,029$90K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd44,763$0.40M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/18/2026VARCOV Co.29,109$0.26M0.1%N/A0.025%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC1,737,450$15.62M0.1%+7.9%1.500%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC29,493$0.27M0.1%+116.4%0.025%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.17,287$0.16M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP15,289$0.14M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Fundamental Investments LLC69,226$0.62M0.0%-55.7%0.060%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd216,041$1.94M0.0%N/A0.187%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC126,426$1.14M0.0%-79.2%0.109%Search for SEC Filing on Google Icon
2/18/2026Man Group plc13,459$0.12M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP83,051$0.75M0.0%-15.5%0.072%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC1,156,000$10.39M0.1%+72.0%0.998%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP88,406$0.80M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC55,261$0.50M0.0%+28.2%0.048%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC75,244$0.68M0.0%+307.9%0.065%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC121,541$1.09M0.1%-22.5%0.105%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC313,695$2.82M0.0%+49.1%0.271%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers50,601$0.46M0.0%+37.7%0.044%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC98,764$0.89M0.0%-13.8%0.085%Search for SEC Filing on Google Icon
2/17/2026Amundi10,161$91K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD121,988$1.10M0.0%+31.9%0.105%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.23,122$0.21M0.0%+13.5%0.020%Search for SEC Filing on Google Icon
2/17/2026Himension Capital Singapore PTE. LTD.578,562$5.20M0.3%+2.4%0.499%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System99,006$0.89M0.0%+10.5%0.085%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.9,599$86K0.0%-15.1%0.008%Search for SEC Filing on Google Icon
2/17/2026Atom Investors LP92,540$0.83M0.1%N/A0.080%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board50,697$0.46M0.0%-7.1%0.044%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors17,653$0.16M0.0%+58.6%0.015%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada39,378$0.36M0.0%-91.5%0.034%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL18,160$0.16M0.0%-9.9%0.016%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.29,346$0.26M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.99,301$0.89M0.0%-50.0%0.086%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP37,142$0.33M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC511,240$4.60M0.0%+4.7%0.441%Search for SEC Filing on Google Icon
2/16/2026Aptus Capital Advisors LLC10,140$91K0.0%-85.8%0.009%Search for SEC Filing on Google Icon
2/13/2026Arete Wealth Advisors LLC30,843$0.28M0.0%+103.3%0.027%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co24,152$0.22M0.0%-3.5%0.021%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP223,166$2.01M0.0%N/A0.193%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp931,391$8.37M0.0%+19.6%0.804%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP315,000$2.83M0.0%+37.0%0.272%Search for SEC Filing on Google Icon
2/13/2026Gen Wealth Partners Inc33,315$0.30M0.0%+528.2%0.029%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC215,428$1.94M0.0%+17.7%0.186%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP276,855$2.49M0.0%+2,493.2%0.239%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC243,903$2.19M0.2%+309.1%0.211%Search for SEC Filing on Google Icon
2/13/2026Birchview Capital LP315,400$2.84M1.7%+425.7%0.272%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.945,756$8.50M0.0%+8.3%0.817%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey26,127$0.24M0.0%-8.6%0.023%Search for SEC Filing on Google Icon
2/13/2026State Street Corp6,418,836$57.71M0.0%+29.1%5.542%Search for SEC Filing on Google Icon
2/13/2026Van ECK Associates Corp5,391$48K0.0%+104.2%0.005%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P36,953$0.33M0.0%-13.3%0.032%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC239,247$2.15M0.0%-0.8%0.207%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN433,742$3.90M0.0%-19.6%0.374%Search for SEC Filing on Google Icon
2/13/2026Banco Santander S.A.13,029$0.12M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/12/2026Wasatch Advisors LP313,685$2.82M0.0%N/A0.271%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP764,890$6.88M0.0%N/A0.660%Search for SEC Filing on Google Icon
2/12/2026Insigneo Advisory Services LLC10,030$90K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC56,606$0.51M0.0%-7.2%0.049%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC93,811$0.84M0.0%+4.7%0.081%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC1,672,700$15.04M0.0%+156.9%1.444%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP1,931,849$17.37M0.0%+9.9%1.668%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.354,947$3.19M0.0%+10,777.9%0.306%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc8,069$73K0.0%-62.3%0.007%Search for SEC Filing on Google Icon
2/12/2026AlphaCentric Advisors LLC10,880$98K0.1%N/A0.009%Search for SEC Filing on Google Icon
2/12/2026Elevation Point Wealth Partners LLC86,573$0.78M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/12/2026Marex Group plc623,601$5.61M0.0%+0.2%0.538%Search for SEC Filing on Google Icon
2/12/2026IQ EQ FUND MANAGEMENT IRELAND Ltd731,421$6.58M0.5%+47.9%0.631%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund24,656$0.22M0.0%-13.0%0.021%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC55,319$0.50M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/12/2026Discovery Value Fund97,976$0.88M2.3%-57.2%0.085%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank201,000$1.81M0.0%+5.4%0.174%Search for SEC Filing on Google Icon
2/11/2026ARK Investment Management LLC14,207,324$127.72M0.8%+19.2%12.266%Search for SEC Filing on Google Icon
2/11/2026GWN Securities Inc.20,843$0.19M0.0%+65.1%0.018%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG153,497$1.38M0.0%+1.5%0.133%Search for SEC Filing on Google Icon
2/11/2026Amova Asset Management Americas Inc.2,192,461$19.69M0.2%-6.9%1.893%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC120,297$1.08M0.0%+16.8%0.104%Search for SEC Filing on Google Icon
2/11/2026Contrarius Group Holdings Ltd714,480$6.42M0.3%-87.9%0.617%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.743,698$6.69M0.0%+67.1%0.642%Search for SEC Filing on Google Icon
2/11/2026Dearborn Partners LLC17,454$0.16M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/11/2026Havemeyer Place LP7,916$71K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/11/2026IvyRock Asset Management HK Ltd19,330$0.17M0.1%+34.9%0.017%Search for SEC Filing on Google Icon
2/10/2026Intellectus Partners LLC51,125$0.46M0.1%-41.2%0.044%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.1,455,619$13.09M0.0%-66.0%1.257%Search for SEC Filing on Google Icon
2/10/2026Grandfield & Dodd LLC48,220$0.43M0.0%-5.1%0.042%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets591,277$5.32M0.0%+1,076.6%0.510%Search for SEC Filing on Google Icon
2/10/2026Northwestern Mutual Wealth Management Co.9,186$83K0.0%+29.7%0.008%Search for SEC Filing on Google Icon
2/10/2026Jupiter Asset Management Ltd.1,037,918$9.33M0.1%-23.8%0.896%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC58,029$0.52M0.0%+30.1%0.050%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC2,696,187$24.24M0.0%+4.1%2.328%Search for SEC Filing on Google Icon
2/6/2026Axxcess Wealth Management LLC21,399$0.19M0.0%+20.1%0.018%Search for SEC Filing on Google Icon
2/6/2026Nano Cap New Millennium Growth Fund L P12,500$0.11M0.1%N/A0.011%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG56,790$0.51M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP233,080$2.10M0.2%+210.4%0.201%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB33,800$0.30M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC79,664$0.72M0.0%+101.2%0.069%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intellia Therapeutics logo
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More on Intellia Therapeutics

Today's Range

Now: $12.38
Low: $12.30
High: $13.16

50 Day Range

MA: $13.16
Low: $11.09
High: $15.90

52 Week Range

Now: $12.38
Low: $5.90
High: $28.25

Volume

2,066,295 shs

Average Volume

4,878,648 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Who are the company insiders with the largest holdings of Intellia Therapeutics?

Intellia Therapeutics' top insider investors include:
  1. John M Leonard (CEO)
  2. John M Leonard (CEO)
  3. Nessan Bermingham (CEO)
  4. Jose E Rivera (EVP)
  5. William J Chase (Director)
  6. Edward J Dulac III (EVP)
  7. Birgit C Schultes (EVP)
  8. James Basta (EVP)
  9. Eliana Clark (EVP)
  10. Michael P Dube (CAO)
Learn More about top insider investors at Intellia Therapeutics.

Who are the major institutional investors of Intellia Therapeutics?

Intellia Therapeutics' top institutional shareholders include:
  1. ARK Investment Management LLC — 12.27%
  2. Vanguard Group Inc. — 11.23%
  3. State Street Corp — 5.54%
  4. Geode Capital Management LLC — 2.33%
  5. Sumitomo Mitsui Trust Group Inc. — 1.89%
  6. Amova Asset Management Americas Inc. — 1.89%
Learn More about top institutional investors of Intellia Therapeutics stock.

Which institutional investors are selling Intellia Therapeutics stock?

Within the previous quarter, NTLA stock was sold by these institutional investors:
  1. Contrarius Group Holdings Ltd
  2. Goldman Sachs Group Inc.
  3. Millennium Management LLC
  4. Royal Bank of Canada
  5. Jupiter Asset Management Ltd.
  6. Sumitomo Mitsui Trust Group Inc.
  7. Amova Asset Management Americas Inc.
  8. Walleye Capital LLC
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
  1. John M Leonard (CEO)
  2. John M Leonard (CEO)
  3. Nessan Bermingham (CEO)
  4. Jose E Rivera (EVP)
  5. William J Chase (Director)
  6. Edward J Dulac III (EVP)
  7. Birgit C Schultes (EVP)
  8. James Basta (EVP)
Learn More investors selling Intellia Therapeutics stock.

Which institutional investors are buying Intellia Therapeutics stock?

Within the last quarter, NTLA stock was purchased by institutional investors including:
  1. ARK Investment Management LLC
  2. Vanguard Group Inc.
  3. State Street Corp
  4. Renaissance Technologies LLC
  5. HRT Financial LP
  6. BNP Paribas Financial Markets
  7. Armistice Capital LLC
  8. Federated Hermes Inc.

Intellia Therapeutics Active Insiders

John M. Leonard
John M. Leonard (Age 68)
CEO
1 recent trades
Andrew Schiermeier
Andrew Schiermeier
COO
Glenn Goddard
Glenn Goddard (Age 55)
CFO
Michael P Dube
Michael P Dube (Age 48)
CAO
1 recent trades
Jean Francois Formela
Jean Francois Formela
Director
John F Crowley
John F Crowley
Director
Caroline Dorsa
Caroline Dorsa
Director
Jesse Goodman
Jesse Goodman
Director
William J Chase
Director
James Basta
James Basta
EVP, General Counsel and Corporate Secretary
1 recent trades
David Lebwohl
David Lebwohl (Age 71)
EVP
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino (Age 65)
EVP
Jose E Rivera
Jose E Rivera
EVP
Eliana Clark
Eliana Clark
EVP
Birgit C Schultes
Birgit C Schultes
EVP
2 recent trades
Edward J Dulac III
Edward J Dulac III (Age 50)
EVP